Published 2003 | Version v1

Publication Metadata-only

CMF vs tamoxifen (TMX) plus goserelin (GOS) as adjuvant treatment of ER positive (ER+ve) premenopausal breast cancer. Updated results of a multicentric trial

Creators: BOCCARDO, FRANCESCO; Rubagotti, A; Amoroso, D; Mesiti, M; Romeo, D; Sismondi, P; Distante, V.

Others:: Boccardo, Francesco; Rubagotti, A; Amoroso, D; Mesiti, M; Romeo, D; Sismondi, P; Distante, V.

Additional details

Created:: April 14, 2023
Modified:: November 28, 2023